← Back to Clinical Trials
Recruiting NCT06096324

NCT06096324 Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06096324
Status Recruiting
Phase —
Sponsor University of North Carolina, Chapel Hill
Condition Economic Hardship
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2023-09-19
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 24 Years
Study Type INTERVENTIONAL
Interventions
Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.Job announcements

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2023-09-19 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study team will conduct a two-group study to examine the efficacy of implementing a combination intervention to improve economic stability and HIV preventive behaviors. The team will enroll approximately 500 young adults. Participants will be randomly assigned to one of two groups. The first group ("control") will receive text messages with information on job openings. The second group ("intervention") will receive text messages with information on job openings plus HIV prevention text messages, educational sessions on employment, income generation, and HIV prevention, economic resources, and mentoring.

Eligibility Criteria

Inclusion criteria are: * Aged 18-24 * Economically-vulnerable in past 12 months * Sexually active in past 12 months * Living in Baltimore * Has access to mobile phone with text messaging Exclusion criteria are: * Aged 17 or younger * Older than 24 years * Unwilling to provide consent for study participation

Contact & Investigator

Central Contact

Larissa Jennings Mayo-Wilson, PhD MHS

✉ ljennings.mayowilson@unc.edu

📞 919-445-5099

Principal Investigator

Larissa Jennings Mayo-Wilson, PhD MHS

PRINCIPAL INVESTIGATOR

University of North Carolina, Chapel Hill

Frequently Asked Questions

Who can join the NCT06096324 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 24 Years, studying Economic Hardship. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06096324 currently recruiting?

Yes, NCT06096324 is actively recruiting participants. Contact the research team at ljennings.mayowilson@unc.edu for enrollment information.

Where is the NCT06096324 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT06096324 clinical trial?

NCT06096324 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Larissa Jennings Mayo-Wilson, PhD MHS at University of North Carolina, Chapel Hill. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology